Cargando…
An essential role for decorin in bladder cancer invasiveness
Muscle-invasive forms of urothelial carcinomas are responsible for most mortality in bladder cancer. Finding new treatments for invasive bladder tumours requires adequate animal models to decipher the mechanisms of progression, in particular the way tumours interact with their microenvironment. Here...
Autores principales: | El Behi, Mohamed, Krumeich, Sophie, Lodillinsky, Catalina, Kamoun, Aurélie, Tibaldi, Lorenzo, Sugano, Gaël, De Reynies, Aurélien, Chapeaublanc, Elodie, Laplanche, Agnès, Lebret, Thierry, Allory, Yves, Radvanyi, François, Lantz, Olivier, Eiján, Ana María, Bernard-Pierrot, Isabelle, Théry, Clotilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914526/ https://www.ncbi.nlm.nih.gov/pubmed/24142880 http://dx.doi.org/10.1002/emmm.201302655 |
Ejemplares similares
Ejemplares similares
-
A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
por: Vallot, Céline, et al.
Publicado: (2011) -
Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015) -
IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer
por: Neuzillet, Yann, et al.
Publicado: (2017) -
Deregulation of Rab and Rab Effector Genes in Bladder Cancer
por: Ho, Joel R., et al.
Publicado: (2012) -
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
por: Lang, Hervé, et al.
Publicado: (2022)